Literature DB >> 12033944

PAK1 kinase is required for CXCL1-induced chemotaxis.

Dingzhi Wang1, Jiging Sai, Glendora Carter, Aristidis Sachpatzidis, Elias Lolis, Ann Richmond.   

Abstract

The CXC subfamily of chemokines plays an important role in diverse processes, including inflammation, wound healing, growth regulation, angiogenesis, and tumorigenesis. The CXC chemokine CXCL1, or MGSA/GROalpha, is traditionally considered to be responsible for attracting leukocytes into sites of inflammation. To better understand the molecular mechanisms by which CXCL1 induces CXCR2-mediated chemotaxis, the signal transduction components involved in CXCL1-induced chemotaxis were examined. It is shown here that CXCL1 induces cdc42 and PAK1 activation in CXCR2-expressing HEK293 cells. Activation of the cdc42-PAK1 cascade is required for CXCL1-induced chemotaxis but not for CXCL1-induced intracellular Ca2+ mobilization. Moreover, CXCL1 activation of PAK1 is independent of ERK1/2 activation, a conclusion based on the observations that the inhibition of MEK-ERK activation by expression of dominant negative ERK or by the MEK inhibitor, PD98059, has no effect on CXCL1-induced PAK1 activation or CXCL1-induced chemotaxis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033944      PMCID: PMC2668253          DOI: 10.1021/bi025902m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  53 in total

1.  Interaction of paxillin with p21-activated Kinase (PAK). Association of paxillin alpha with the kinase-inactive and the Cdc42-activated forms of PAK3.

Authors:  S Hashimoto; A Tsubouchi; Y Mazaki; H Sabe
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

2.  Control of cell polarity and chemotaxis by Akt/PKB and PI3 kinase through the regulation of PAKa.

Authors:  C Y Chung; G Potikyan; R A Firtel
Journal:  Mol Cell       Date:  2001-05       Impact factor: 17.970

3.  IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways.

Authors:  I U Schraufstatter; J Chung; M Burger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-06       Impact factor: 5.464

Review 4.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

Review 5.  Rho GTPases and signaling networks.

Authors:  L Van Aelst; C D'Souza-Schorey
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

Review 6.  Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways.

Authors:  L Lim; E Manser; T Leung; C Hall
Journal:  Eur J Biochem       Date:  1996-12-01

7.  Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis.

Authors:  W Yang; W P Schraw; S G Mueller; A Richmond
Journal:  Biochemistry       Date:  1997-12-09       Impact factor: 3.162

8.  Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1.

Authors:  S Zhang; J Han; M A Sells; J Chernoff; U G Knaus; R J Ulevitch; G M Bokoch
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

9.  PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia.

Authors:  A Abo; J Qu; M S Cammarano; C Dan; A Fritsch; V Baud; B Belisle; A Minden
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

Review 10.  Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression.

Authors:  J Luan; R Shattuck-Brandt; H Haghnegahdar; J D Owen; R Strieter; M Burdick; C Nirodi; D Beauchamp; K N Johnson; A Richmond
Journal:  J Leukoc Biol       Date:  1997-11       Impact factor: 4.962

View more
  20 in total

1.  Differential effects of substrate modulus on human vascular endothelial, smooth muscle, and fibroblastic cells.

Authors:  Karyn G Robinson; Ting Nie; Aaron D Baldwin; Elaine C Yang; Kristi L Kiick; Robert E Akins
Journal:  J Biomed Mater Res A       Date:  2012-02-28       Impact factor: 4.396

2.  Blocking p21-activated kinase reduces lipopolysaccharide-induced acute lung injury by preventing polymorphonuclear leukocyte infiltration.

Authors:  Jörg Reutershan; Rebecca Stockton; Alexander Zarbock; Gail W Sullivan; Daniel Chang; David Scott; Martin A Schwartz; Klaus Ley
Journal:  Am J Respir Crit Care Med       Date:  2007-02-22       Impact factor: 21.405

Review 3.  Chemokines, chemokine receptors and the gastrointestinal system.

Authors:  Hiroshi Miyazaki; Kazuaki Takabe; W Andrew Yeudall
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

Review 4.  Chemokine receptor internalization and intracellular trafficking.

Authors:  Nicole F Neel; Evemie Schutyser; Jiqing Sai; Guo-Huang Fan; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2005-07-05       Impact factor: 7.638

5.  Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity.

Authors:  Dayanidhi Raman; Snjezana-Zaja Milatovic; Dejan Milatovic; Ryan Splittgerber; Guo-Huang Fan; Ann Richmond
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-17       Impact factor: 4.219

Review 6.  P21-activated kinase in inflammatory and cardiovascular disease.

Authors:  Domenico M Taglieri; Masuko Ushio-Fukai; Michelle M Monasky
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

7.  CXCL5 overexpression is associated with late stage gastric cancer.

Authors:  Jeong Youp Park; Kyung Hwa Park; Seungmin Bang; Myoung Hwan Kim; Ji-Eun Lee; Jingu Gang; Sang Seok Koh; Si Young Song
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-04       Impact factor: 4.553

8.  p21-activated kinase signaling regulates oxidant-dependent NF-kappa B activation by flow.

Authors:  A Wayne Orr; Cornelia Hahn; Brett R Blackman; Martin Alexander Schwartz
Journal:  Circ Res       Date:  2008-07-31       Impact factor: 17.367

9.  Upregulation of C-X-C chemokine receptor type 1 expression is associated with late-stage gastric adenocarcinoma.

Authors:  Jun Pu Wang; Wan Ming Hu; Kuan Song Wang; Bai Hua Luo; Chang Wu; Zhi Hong Chen; Geng Qiu Luo; Yu Wu Liu; Qin Lai Liu; Jun Yu; Jing He Li; Ji Fang Wen
Journal:  Exp Ther Med       Date:  2012-05-07       Impact factor: 2.447

10.  LIM and SH3 protein-1 modulates CXCR2-mediated cell migration.

Authors:  Dayanidhi Raman; Jiqing Sai; Nicole F Neel; Catherine S Chew; Ann Richmond
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.